Addiction journal

Addiction Audio

Addiction journal

  • Opioid agonist treatment, drug related deaths and dynamic models with Matt Hickman

Opioid agonist treatment, drug related deaths and dynamic models with Matt Hickman

Sunday 14th August 2022

Professor Matt Hickman explains how Opioid Agonist Treatment (OAT) reduces drug-related deaths using population modelling in this episode of Addiction Audio.
18 minutes
Informative
Educational
Engaging
Thought-provoking
Compelling

About this podcast

Addiction Audio
Author:
Addiction journal
Overview:
Categories:
Navigating Alcohol Dependency
Understanding Addiction & Recovery
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Links:
Visit site
Episodes:
87 (View all)
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Matt Hickman on Opioid Agonist Treatment: Saving Lives Through Population Modelling

Without OAT, the number of overdose deaths would have been at least higher.
What if you could predict how many lives a treatment could save? In this episode of 'Addiction Audio', Professor Matt Hickman dives into the fascinating world of population modelling to explore the impact of Opioid Agonist Treatment (OAT) on drug-related deaths. Hickman shares insights from his research, revealing that without OAT, overdose deaths in New South Wales, Australia, would have been 50% higher.
The conversation delves into the nuts and bolts of creating dynamic models that match incarceration and OAT records, alongside findings from systematic reviews. Hickman explains how these models offer a hypothetical glimpse into what mortality rates might look like without OAT, highlighting the crucial role of treatment retention in reducing deaths. This episode is a must-listen for policymakers and anyone interested in the science behind addiction treatment.
It raises critical questions about the effectiveness of OAT programmes and offers valuable insights into how services can be improved to save more lives. Tune in to understand the life-saving potential of OAT and the importance of keeping people in treatment during those initial high-risk periods.